$1.73 -0.03 (-1.73%)

Liminatus Pharma, Inc. Class A Common Stock (LIMN)
Liminatus Pharma, Inc. Class A (LIMN) is a pharmaceutical company focused on developing and commercializing innovative therapies. The company emphasizes advancing treatments through cutting-edge research and scientific discovery, aiming to address unmet medical needs across various therapeutic areas.